Lower riskDrug recall · FDA · Published February 6, 2025
Sun Pharmaceutical Morphine Sulfate Tablets Recall: Failed Dissolution Specifications
Sun Pharmaceutical recalls 100mg Morphine Sulfate Extended-Release Tablets (100-count) due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 63304-452-01 and lot number AD16615.
“Sun Pharmaceutical Morphine Sulfate Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32296-sun-pharmaceutical-morphine-sulfate-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0249-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0249-2025%22&limit=1).
Sun Pharmaceutical Industries Inc. recalled Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles due to failed dissolution specifications, the FDA said on Feb. 6, 2025.
The recall is due to failed dissolution specifications for the drug, according to the FDA.
Context
GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (Sept. 14, 2026), Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026). Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), Mylan Acamprosate Tablets Recall (July 24, 2026), and Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026).
How to tell if you have this one
Check for the NDC code 63304-452-01 and lot number AD16615 on the bottle. The product is a prescription-only medication sold by Sun Pharmaceutical in the US.
Brand
Sun Pharmaceutical
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for NDC 63304-452-01 and lot number AD16615 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 34 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0249-2025 (February 6, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0249-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.